216 related articles for article (PubMed ID: 26213467)
1. Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system.
Guo L; Zhang H; Wang F; Liu P; Wang Y; Xia G; Liu R; Li X; Yin H; Jiang H; Chen B
Int J Nanomedicine; 2015; 10():4535-47. PubMed ID: 26213467
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
3. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.
Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B
Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961
[TBL] [Abstract][Full Text] [Related]
4. Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation.
Bao W; Liu R; Xia G; Wang F; Chen B
Drug Des Devel Ther; 2019; 13():1107-1115. PubMed ID: 31040647
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility Assessment of Polyethylene Glycol-Poly L-Lysine-Poly Lactic-Co-Glycolic Acid Nanoparticles In Vitro and In Vivo.
Guo L; Chen B; Liu R; Xia G; Wang Y; Li X; Wei C; Wang X; Jiang H
J Nanosci Nanotechnol; 2015 May; 15(5):3710-9. PubMed ID: 26504996
[TBL] [Abstract][Full Text] [Related]
6. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
7. Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells.
Liu P; Zhang H; Wu X; Guo L; Wang F; Xia G; Chen B; Yin H; Wang Y; Li X
Onco Targets Ther; 2016; 9():5049-59. PubMed ID: 27574446
[TBL] [Abstract][Full Text] [Related]
8. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
9. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil.
Liu P; Wang H; Wang Q; Sun Y; Shen M; Zhu M; Wan Z; Duan Y
J Nanosci Nanotechnol; 2012 Jun; 12(6):4467-71. PubMed ID: 22905486
[TBL] [Abstract][Full Text] [Related]
10. Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.
Yin P; Wang Y; Qiu Y; Hou L; Liu X; Qin J; Duan Y; Liu P; Qiu M; Li Q
Int J Nanomedicine; 2012; 7():3961-9. PubMed ID: 22888239
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional Polyethylene Glycol (PEG)-Poly (Lactic-Co-Glycolic Acid) (PLGA)-Based Nanoparticles Loading Doxorubicin and Tetrahydrocurcumin for Combined Chemoradiotherapy of Glioma.
Zhang X; Zhao L; Zhai G; Ji J; Liu A
Med Sci Monit; 2019 Dec; 25():9737-9751. PubMed ID: 31856143
[TBL] [Abstract][Full Text] [Related]
12. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
[TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance in xenograft nude-mice by magnetic Fe(3)O(4) nanoparticles combined with daunorubicin and 5-bromotetrandrine.
Wu YN; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):60-4. PubMed ID: 19236748
[TBL] [Abstract][Full Text] [Related]
14. TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells.
Wang DF; Rong WT; Lu Y; Hou J; Qi SS; Xiao Q; Zhang J; You J; Yu SQ; Xu Q
ACS Appl Mater Interfaces; 2015 Feb; 7(7):3888-901. PubMed ID: 25644220
[TBL] [Abstract][Full Text] [Related]
15. cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer.
Liu P; Qin L; Wang Q; Sun Y; Zhu M; Shen M; Duan Y
Biomaterials; 2012 Oct; 33(28):6739-47. PubMed ID: 22763223
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional Nanoparticles Loading with Docetaxel and GDC0941 for Reversing Multidrug Resistance Mediated by PI3K/Akt Signal Pathway.
Wang Y; Li J; Chen JJ; Gao X; Huang Z; Shen Q
Mol Pharm; 2017 Apr; 14(4):1120-1132. PubMed ID: 28291364
[TBL] [Abstract][Full Text] [Related]
17. Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers: poly(lactic acid)-poly(ethylene glycol)-poly(L-lysine) to enhance paclitaxel target delivery.
Liu Y; Liu C; Li M; Liu F; Feng L; Zhang L; Zhang N
J Biomed Nanotechnol; 2014 Jun; 10(6):948-58. PubMed ID: 24749390
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional nanoparticles as nanocarrier for vincristine sulfate delivery to overcome tumor multidrug resistance.
Wang Y; Dou L; He H; Zhang Y; Shen Q
Mol Pharm; 2014 Mar; 11(3):885-94. PubMed ID: 24483832
[TBL] [Abstract][Full Text] [Related]
20. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
